A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects
Clinical trial NCT03557580 · COMPLETED
Trial details
- NCT number
- NCT03557580
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-17
- Primary completion
- 2018-05-06
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.